Literature DB >> 11426780

Thrombus formation after the Fontan operation.

P D Coon1, J Rychik, R T Novello, P S Ro, J W Gaynor, T L Spray.   

Abstract

BACKGROUND: Thrombus formation is common after a Fontan operation. We investigated the frequency and location of thrombus in our population of children based on the type of Fontan operation performed. METHODS AND
RESULTS: Between January 1987 and January 1999, 592 patients underwent echocardiography after Fontan operation and 52 (8.8%) had intracardiac thrombus. Median age at Fontan operation was 1.9 years (range 0.8 to 35.1). Freedom from thrombus was 92%, 90%, 84% and 82% at 1, 3, 8, and 10 years after Fontan operation, respectively. There was no difference in freedom from thrombus, based on type of operation (atriopulmonary vs. lateral tunnel) or presence of fenestration. Thrombus was detected in the systemic venous atrium in 26 (48%), in the pulmonary venous atrium in 22 (44%), in both atria in 1 (2%), in the hypoplastic left ventricular cavity in 2 (8%), and in the ligated pulmonary artery stump in 1 (2%).
CONCLUSIONS: Thrombus formation occurs with equal frequency in all types of modifications and is seen in the pulmonary, as well as the systemic venous atria. Our study suggests that thrombus formation is inherent to the physiology after Fontan operation and is not related to the type of modification performed.

Entities:  

Mesh:

Year:  2001        PMID: 11426780     DOI: 10.1016/s0003-4975(01)02472-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  37 in total

1.  Prophylactic anticoagulation following the Fontan operation.

Authors:  H A Walker; M A Gatzoulis
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

2.  Anaesthetic management of a patient with Fontan physiology for electrophysiology study and catheter ablation.

Authors:  Denise Yan Yin Lim; Thangavelautham Suhitharan; Harikrishnan Kothandan
Journal:  BMJ Case Rep       Date:  2019-03-31

3.  Recurrent thrombosis despite a therapeutic international normalised ratio.

Authors:  Amy Carroll; Linda Griffiths; Vaikom Mahadevan; Jaspal Dua; Jecko Thachil
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

Review 4.  Current Therapy for Hypoplastic Left Heart Syndrome and Related Single Ventricle Lesions.

Authors:  Richard G Ohye; Dietmar Schranz; Yves D'Udekem
Journal:  Circulation       Date:  2016-10-25       Impact factor: 29.690

Review 5.  Thromboembolism and the role of anticoagulation in the Fontan patient.

Authors:  M L Jacobs; K K Pourmoghadam
Journal:  Pediatr Cardiol       Date:  2007 Nov-Dec       Impact factor: 1.655

6.  Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.

Authors:  L Idorn; A S Jensen; K Juul; J I Reimers; P I Johansson; K E Sørensen; S R Ostrowski; L Søndergaard
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

7.  Fontan fenestration closure and event-free survival.

Authors:  Bartlomiej R Imielski; Ronald K Woods; Kathleen A Mussatto; Yumei Cao; Pippa M Simpson; James S Tweddell
Journal:  J Thorac Cardiovasc Surg       Date:  2012-10-09       Impact factor: 5.209

8.  Congenital heart disease in pregnancy.

Authors:  Anselm Uebing; Michael A Gatzoulis; Constantin von Kaisenberg; Hans-Heiner Kramer; Alexander Strauss
Journal:  Dtsch Arztebl Int       Date:  2008-05-09       Impact factor: 5.594

9.  Transesophageal echocardiography of intracardiac thrombus in congenital heart disease and atrial flutter: the importance of thorough examination of the Fontan.

Authors:  Nida Yousef; Molly Philips; Ira Shetty; Vivian Wei Cui; Frank Zimmerman; David A Roberson
Journal:  Pediatr Cardiol       Date:  2014-04-20       Impact factor: 1.655

Review 10.  Modeling the Fontan circulation: where we are and where we need to go.

Authors:  C G DeGroff
Journal:  Pediatr Cardiol       Date:  2007-10-05       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.